Loading provider…
Loading provider…
Allergy & Immunology Physician in Riverside, CA
NPI: 1366429730Primary Practice Location
Riverside Medical Clinic-Moreno Valley
7117 Brockton Ave, Riverside, CA
Primary Employer
Riverside Medical Clinic-Moreno Valley
riversidemedicalclinic.com
HQ Phone
Get M.D. William's Phone Numberphone_androidMobile
Get M.D. William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
CA State Medical License
CA State Medical License
2008 - 2026
MN State Medical License
2004 - 2009
FL State Medical License
2006 - 2008

American Board of Allergy and Immunology
Allergy & Immunology
UC Irvine School of Medicine
medschool.uci.edu
Medical School
Until 2003
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Allergy and Immunology
2006 - 2008
Residency • Internal Medicine
2003 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 61 | 86 |
| 2 | 95004Injection of allergenic extracts into skin, accessed through the skin | 41 | 2,875 |
| 3 | 99203New patient outpatient visit, total time 30-44 minutes | 29 | 29 |
| 4 | 95117Injection of incremental dosages of allergen, 2 or more injections | 21 | 307 |
| 5 | 95165Preparation and provision of single or multiple antigens for allergen immunotherapy | 21 | 442 |
Chronic rhinosinusitis in adults.
Authors: Cherry, W. B., Li, J. T.
Rectus sheath hematoma: review of 126 cases at a single institution.
Authors: Paul Mueller
Journal: Medicine (Baltimore)
A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.
Authors: Cherry, W Brett, Yoon, Juhan, Bartemes, Kathleen R, Iijima, Koji, Kita, Hirohito
Journal: J Allergy Clin Immunol
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: FF/VI via ELLIPTA DPI, DRUG: FF via ELLIPTA DPI